Offer - Urjas Oil for just ₹ 1 X
Pregastar Plus SR 75 Tablet (10), a prescription drug, is manufactured in various forms such as Tablet. Pregastar Plus SR 75 Tablet (10) also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Pregastar Plus SR 75 Tablet (10). Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
Common side effects of Pregastar Plus SR 75 Tablet (10) include Nausea or vomiting, Rash, Gastritis. Besides the aforementioned side effects, there are other adverse effects of Pregastar Plus SR 75 Tablet (10) as well, which are listed below. Normally, these side effects of Pregastar Plus SR 75 Tablet (10) are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Pregastar Plus SR 75 Tablet (10) has a Safe effect for pregnant women and Safe effect on lactating mothers. Warnings related to Pregastar Plus SR 75 Tablet (10)'s effects on the liver, heart and kidney, if any, have been listed below.
Pregastar Plus SR 75 Tablet (10) can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Pregastar Plus SR 75 Tablet (10) in conditions like Drug Allergy, Drug Allergy, Seizures. Other conditions have been mentioned below in the Pregastar Plus SR 75 Tablet (10) contraindications section.
Drug reaction of Pregastar Plus SR 75 Tablet (10) with other medicines has been reported. See below for a complete list.
You should also be aware that Pregastar Plus SR 75 Tablet (10) is safe while driving, and is addiction.
Pregastar Plus SR 75 Tablet (10) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Pregastar Plus SR 75 Tablet (10) safe for pregnant women?
Pregnant women can take Pregastar Plus safely.
Is the use of Pregastar Plus SR 75 Tablet (10) safe during breastfeeding?
Pregastar Plus does not show any side effects in breastfeeding women.
What is the effect of Pregastar Plus SR 75 Tablet (10) on the Kidneys?
Very few cases of side effects of Pregastar Plus on kidney have been reported.
What is the effect of Pregastar Plus SR 75 Tablet (10) on the Liver?
Pregastar Plus may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Pregastar Plus SR 75 Tablet (10) on the Heart?
Side effects of Pregastar Plus on heart are unknown because research on this has not been conducted yet.
If you are suffering from any of the following diseases, you should not take Pregastar Plus SR 75 Tablet (10) unless your doctor advises you to do so -
Is this Pregastar Plus SR 75 Tablet (10) habit forming or addictive?
No, you will not get addicted to Pregastar Plus SR 75 Tablet (10).
Interaction between Food and Pregastar Plus SR 75 Tablet (10)
Eating certain foods may increase the time it takes Pregastar Plus SR 75 Tablet (10) to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Pregastar Plus SR 75 Tablet (10)
No research has been done on this till date. Therefore, it is not known what the effect of taking Pregastar Plus SR 75 Tablet (10) with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Alpha Lipoic Acid
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 609-611
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lyrica (pregabalin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1048-1049
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420